Granules India [GRANULES] vs Caplin Point [CAPLIPOINT] Detailed Stock Comparison

Granules India Ltd.

NSE
Loading...

Caplin Point Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Granules India Ltd. wins in 9 metrics, Caplin Point Laboratories Ltd. wins in 11 metrics, with 0 ties. Caplin Point Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Granules India Ltd. Caplin Point Laboratories Ltd. Better
P/E Ratio (TTM) 29.90 21.79 Caplin Point Laboratories Ltd.
Price-to-Book Ratio 4.10 4.36 Granules India Ltd.
Debt-to-Equity Ratio 45.37 0.17 Caplin Point Laboratories Ltd.
PEG Ratio 1.08 0.86 Caplin Point Laboratories Ltd.
EV/EBITDA 16.93 17.17 Granules India Ltd.
Profit Margin (TTM) 10.71% 29.34% Caplin Point Laboratories Ltd.
Operating Margin (TTM) 16.90% 31.40% Caplin Point Laboratories Ltd.
EBITDA Margin (TTM) 16.90% 31.40% Caplin Point Laboratories Ltd.
Return on Equity 13.50% 18.58% Caplin Point Laboratories Ltd.
Return on Assets (TTM) 8.02% 16.72% Caplin Point Laboratories Ltd.
Free Cash Flow (TTM) $2.95B $2.41B Granules India Ltd.
Dividend Yield 0.30% 0.38% Caplin Point Laboratories Ltd.
1-Year Return 50.46% 12.50% Granules India Ltd.
Price-to-Sales Ratio (TTM) 3.27 6.43 Granules India Ltd.
Enterprise Value $173.92B $125.41B Granules India Ltd.
EV/Revenue Ratio 3.42 6.00 Granules India Ltd.
Gross Profit Margin (TTM) 63.60% 60.36% Granules India Ltd.
Revenue per Share (TTM) $210 $275 Caplin Point Laboratories Ltd.
Earnings per Share (Diluted) $22.50 $81.15 Caplin Point Laboratories Ltd.
Beta (Stock Volatility) -0.08 0.11 Granules India Ltd.

Granules India Ltd. vs Caplin Point Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

GRANULES
CAPLIPOINT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Granules India Ltd.-2.34%-2.33%1.67%32.01%30.95%20.88%
Caplin Point Laboratories Ltd.-1.79%12.01%18.30%44.54%20.91%31.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Granules India Ltd.50.46%162.44%146.61%452.60%8,639.45%8,917.06%
Caplin Point Laboratories Ltd.12.50%196.44%268.62%1,154.13%5,989.53%5,989.53%

Performance & Financial Health Analysis: Granules India Ltd. vs Caplin Point Laboratories Ltd.

MetricGRANULESCAPLIPOINT
Market Information
Market Cap i₹170.22B₹134.62B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,262,37594,210
90 Day Avg. Volume i1,054,74486,832
Last Close₹748.50₹2,364.60
52 Week Range₹432.60 - ₹804.30₹1,500.30 - ₹2,447.30
% from 52W High-6.94%-3.38%
All-Time High₹804.30 (May 29, 2026)₹2,641.00 (Dec 23, 2024)
% from All-Time High-6.94%-10.47%
Growth Metrics
Quarterly Revenue Growth0.22%0.10%
Quarterly Earnings Growth0.28%0.18%
Financial Health
Profit Margin (TTM) i0.11%0.29%
Operating Margin (TTM) i0.17%0.31%
Return on Equity (TTM) i0.14%0.19%
Debt to Equity (MRQ) i45.370.17
Cash & Liquidity
Book Value per Share (MRQ)₹164.06₹405.84
Cash per Share (MRQ)₹25.51₹133.82
Operating Cash Flow (TTM) i₹7.56B₹5.31B
Levered Free Cash Flow (TTM) i₹5.02B₹5.36B
Dividends
Last 12-Month Dividend Yield i0.30%0.38%
Last 12-Month Dividend i₹1.50₹8.50

Valuation & Enterprise Metrics Analysis: Granules India Ltd. vs Caplin Point Laboratories Ltd.

MetricGRANULES (Apr 24, 2026)CAPLIPOINT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i29.9021.79
Forward P/E i22.3519.30
PEG Ratio i1.080.86
Price to Sales (TTM) i3.276.43
Price to Book (MRQ) i4.104.36
Market Capitalization
Market Capitalization i₹170.22B₹134.62B
Enterprise Value i₹173.92B₹125.41B
Enterprise Value Metrics
Enterprise to Revenue i3.426.00
Enterprise to EBITDA i16.9317.17
Risk & Other Metrics
Beta i-0.080.11
Book Value per Share (MRQ) i₹164.06₹405.84

Financial Statements Comparison: Granules India Ltd. vs Caplin Point Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGRANULES (2025)CAPLIPOINT (2025)
Revenue/Sales i44.56B19.21B
Cost of Goods Sold i18.34B7.78B
COGS % of Revenue i41.1%40.5%
Gross Profit i26.22B11.43B
Gross Margin i58.9%59.5%
Research & Development i2.38B766.80M
Operating Income (EBIT) i7.29B5.87B
Operating Margin i16.4%30.6%
EBITDA i9.25B7.42B
EBITDA Margin i20.8%38.6%
Pre-Tax Income i6.60B6.77B
Pre-Tax Income % of Revenue i14.8%35.2%
Income Tax i1.59B1.36B
Income Tax % of Revenue i3.6%7.1%
Net Income (Profit) i5.02B5.41B
Profit Margin i11.3%28.2%

Balance Sheet & Liquidity Metrics

MetricGRANULES (2025)CAPLIPOINT (2025)
Cash & Equivalents i4.66B5.83B
Total Current Assets i31.15B21.34B
Total Current Assets % of Revenue i69.9%111.1%
Total Current Liabilities i20.03B3.06B
Total Current Liabilities % of Revenue i45.0%15.9%
Long-Term Debt i4.71B29.10M
Long-Term Debt % of Revenue i10.6%0.2%
Total Shareholders Equity i37.16B28.86B
Retained Earnings i30.59B23.69B
Retained Earnings % of Revenue i68.7%123.3%
Property, Plant & Equipment i719.13M1.66B

Cash Flow Statement Comparison

MetricGRANULES (2025)CAPLIPOINT (2025)
Operating Cash Flow i7.56B5.31B
Operating Cash Flow % of Revenue i17.0%27.6%
Capital Expenditures i-5.70B-1.92B
Free Cash Flow i2.95B2.41B
FCF Margin i6.6%12.5%
Debt Repayment i-23.41BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGRANULESCAPLIPOINT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i247.80M76.01M
Float Shares i147.11M20.26M
% Held by Insiders i39.31%73.68%
% Held by Institutions i23.27%5.32%
% Held by Public i37.42%21.00%

Dividend Analysis & Yield Comparison: Granules India Ltd. vs Caplin Point Laboratories Ltd.

MetricGRANULESCAPLIPOINT
Last 12-Month Dividend i₹1.50₹8.50
Last 12-Month Dividend Yield i0.30%0.38%
3-Year Avg Annual Dividend i₹1.50₹5.83
3-Year Avg Dividend Yield i0.33%0.19%
3-Year Total Dividends i₹4.50₹17.50
Ex-Dividend DateJul 31, 2025Sep 12, 2025